A citation-based method for searching scientific literature

Stanislau Yatskevich, Jessie S Kroonen, Claudio Alfieri, Thomas Tischer, Anna C Howes, Linda Clijsters, Jing Yang, Ziguo Zhang, Kaige Yan, Alfred C O Vertegaal, David Barford. Cell Rep 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


SUMO and the robustness of cancer.
Jacob-Sebastian Seeler, Anne Dejean. Nat Rev Cancer 2017
164
100

Src kinases in chondrosarcoma chemoresistance and migration: dasatinib sensitises to doxorubicin in TP53 mutant cells.
J G van Oosterwijk, M A J H van Ruler, I H Briaire-de Bruijn, B Herpers, H Gelderblom, B van de Water, J V M G Bovée. Br J Cancer 2013
42
100

Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs.
Marc Hafner, Mario Niepel, Mirra Chung, Peter K Sorger. Nat Methods 2016
206
100

The SUMO-1 isopeptidase Smt4 is linked to centromeric cohesion through SUMO-1 modification of DNA topoisomerase II.
Jeff Bachant, Annette Alcasabas, Yuval Blat, Nancy Kleckner, Stephen J Elledge. Mol Cell 2002
214
100

Characterization of a new human cell line (CH-3573) derived from a grade II chondrosarcoma with matrix production.
Silvia Calabuig-Fariñas, Rosario Gil Benso, Karoly Szuhai, Isidro Machado, José Antonio López-Guerrero, Danielle de Jong, Amando Peydró, Teresa San Miguel, Lara Navarro, Antonio Pellín,[...]. Pathol Oncol Res 2012
15
100

SUMO, the three Rs and cancer.
J S Seeler, O Bischof, K Nacerddine, A Dejean. Curr Top Microbiol Immunol 2007
57
100

A comprehensive compilation of SUMO proteomics.
Ivo A Hendriks, Alfred C O Vertegaal. Nat Rev Mol Cell Biol 2016
243
100

Targeting SUMO Signaling to Wrestle Cancer.
Jessie S Kroonen, Alfred C O Vertegaal. Trends Cancer 2021
9
100

Dynamic SUMO modification regulates mitotic chromosome assembly and cell cycle progression in Caenorhabditis elegans.
Federico Pelisch, Remi Sonneville, Ehsan Pourkarimi, Ana Agostinho, J Julian Blow, Anton Gartner, Ronald T Hay. Nat Commun 2014
38
100

The SUMO-specific protease SENP5 is required for cell division.
Alessandra Di Bacco, Jian Ouyang, Hsiang-Ying Lee, Andre Catic, Hidde Ploegh, Grace Gill. Mol Cell Biol 2006
130
100

Regulation of DNA damage responses by ubiquitin and SUMO.
Stephen P Jackson, Daniel Durocher. Mol Cell 2013
416
100

Dedifferentiated chondrosarcoma: A survival analysis of 159 cases from the SEER database (2001-2011).
Patrick K Strotman, Taylor J Reif, Stephanie A Kliethermes, Jasmin K Sandhu, Lukas M Nystrom. J Surg Oncol 2017
35
100

Genomics and Therapeutic Vulnerabilities of Primary Bone Tumors.
Katia Scotlandi, Claudia Maria Hattinger, Evelin Pellegrini, Marco Gambarotti, Massimo Serra. Cells 2020
11
100


Ubiquitin-like Protein Conjugation: Structures, Chemistry, and Mechanism.
Laurent Cappadocia, Christopher D Lima. Chem Rev 2018
172
100

A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment.
Marc L Hyer, Michael A Milhollen, Jeff Ciavarri, Paul Fleming, Tary Traore, Darshan Sappal, Jessica Huck, Judy Shi, James Gavin, Jim Brownell,[...]. Nat Med 2018
118
100

Role of SUMO activating enzyme in cancer stem cell maintenance and self-renewal.
Li Du, Yi-Jia Li, Marwan Fakih, Rebecca L Wiatrek, Marjun Duldulao, Zhenbin Chen, Peiguo Chu, Julio Garcia-Aguilar, Yuan Chen. Nat Commun 2016
45
100

SUMO pathway inhibition targets an aggressive pancreatic cancer subtype.
Alexander Biederstädt, Zonera Hassan, Christian Schneeweis, Markus Schick, Lara Schneider, Alexander Muckenhuber, Yingfen Hong, Gerrit Siegers, Lisa Nilsson, Matthias Wirth,[...]. Gut 2020
27
100



Exploration of the chondrosarcoma metabolome; the mTOR pathway as an important pro-survival pathway.
Ruben D Addie, Yvonne de Jong, Gaia Alberti, Alwine B Kruisselbrink, Ivo Que, Hans Baelde, Judith V M G Bovée. J Bone Oncol 2019
10
100

SUMO2 is essential while SUMO3 is dispensable for mouse embryonic development.
Liangli Wang, Carolien Wansleeben, Shengli Zhao, Pei Miao, Wulf Paschen, Wei Yang. EMBO Rep 2014
100
100


Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/Refractory Multiple Myeloma or Lymphoma.
Jatin J Shah, Andrzej J Jakubowiak, Owen A O'Connor, Robert Z Orlowski, R Donald Harvey, Mitchell R Smith, Daniel Lebovic, Catherine Diefenbach, Kevin Kelly, Zhaowei Hua,[...]. Clin Cancer Res 2016
119
100

Screening for potential targets for therapy in mesenchymal, clear cell, and dedifferentiated chondrosarcoma reveals Bcl-2 family members and TGFβ as potential targets.
Jolieke G van Oosterwijk, Danielle Meijer, Maayke A J H van Ruler, Brendy E W M van den Akker, Jan Oosting, Tibor Krenács, Piero Picci, Adrienne M Flanagan, Bernadette Liegl-Atzwanger, Andreas Leithner,[...]. Am J Pathol 2013
30
100

Incidence, outcomes and prognostic factors during 25 years of treatment of chondrosarcomas.
V M van Praag Veroniek, A J Rueten-Budde, V Ho, P D S Dijkstra, M Fiocco, M A J van de Sande. Surg Oncol 2018
49
100

Characterization of the loss of SUMO pathway function on cancer cells and tumor proliferation.
Xingyue He, Jessica Riceberg, Sai M Pulukuri, Steve Grossman, Vaishali Shinde, Pooja Shah, James E Brownell, Larry Dick, John Newcomb, Neil Bence. PLoS One 2015
45
100

SUMO: a regulator of gene expression and genome integrity.
Stefan Müller, Andreas Ledl, Darja Schmidt. Oncogene 2004
221
100

Three new chondrosarcoma cell lines: one grade III conventional central chondrosarcoma and two dedifferentiated chondrosarcomas of bone.
Jolieke G van Oosterwijk, Danielle de Jong, Maayke A J H van Ruler, Pancras C W Hogendoorn, P D Sander Dijkstra, Carla S P van Rijswijk, Isidro Machado, Antonio Llombart-Bosch, Karoly Szuhai, Judith V M G Bovée. BMC Cancer 2012
30
100

The poly-SUMO2/3 protease SENP6 enables assembly of the constitutive centromere-associated network by group deSUMOylation.
Frauke Liebelt, Nicolette S Jansen, Sumit Kumar, Ekaterina Gracheva, Laura A Claessens, Matty Verlaan-de Vries, Edwin Willemstein, Alfred C O Vertegaal. Nat Commun 2019
21
100

SUMOylation-Mediated Regulation of Cell Cycle Progression and Cancer.
Karolin Eifler, Alfred C O Vertegaal. Trends Biochem Sci 2015
136
100

SUMOylation inhibits FOXM1 activity and delays mitotic transition.
S S Myatt, M Kongsema, C W-Y Man, D J Kelly, A R Gomes, P Khongkow, U Karunarathna, S Zona, J K Langer, C W Dunsby,[...]. Oncogene 2014
65
100

The SUMO pathway is essential for nuclear integrity and chromosome segregation in mice.
Karim Nacerddine, François Lehembre, Mantu Bhaumik, Jérôme Artus, Michel Cohen-Tannoudji, Charles Babinet, Pier Paolo Pandolfi, Anne Dejean. Dev Cell 2005
387
100

Marshall Urist Award. Interstitial collagenase gene expression correlates with in vitro invasion in human chondrosarcoma.
S P Scully, K R Berend, A Toth, W N Qi, Z Qi, J A Block. Clin Orthop Relat Res 2000
49
100

SMC5 and MMS21 are required for chromosome cohesion and mitotic progression.
Susanne Behlke-Steinert, Leila Touat-Todeschini, Dimitrios A Skoufias, Robert L Margolis. Cell Cycle 2009
28
100

Pancancer survival analysis of cancer hallmark genes.
Ádám Nagy, Gyöngyi Munkácsy, Balázs Győrffy. Sci Rep 2021
134
100

Sumoylation: a regulatory protein modification in health and disease.
Annette Flotho, Frauke Melchior. Annu Rev Biochem 2013
649
100

Inhibition of mutant IDH1 decreases D-2-HG levels without affecting tumorigenic properties of chondrosarcoma cell lines.
Johnny Suijker, Jan Oosting, Annemarie Koornneef, Eduard A Struys, Gajja S Salomons, Frank G Schaap, Cathelijn J F Waaijer, Pauline M Wijers-Koster, Inge H Briaire-de Bruijn, Lizette Haazen,[...]. Oncotarget 2015
51
100

Guiding Mitotic Progression by Crosstalk between Post-translational Modifications.
Sabine A G Cuijpers, Alfred C O Vertegaal. Trends Biochem Sci 2018
24
100

Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma.
Alexander Hoellein, Mohammad Fallahi, Stephanie Schoeffmann, Sabine Steidle, Franz X Schaub, Martina Rudelius, Iina Laitinen, Lisa Nilsson, Andrei Goga, Christian Peschel,[...]. Blood 2014
49
100

Uncovering SUMOylation dynamics during cell-cycle progression reveals FoxM1 as a key mitotic SUMO target protein.
Joost Schimmel, Karolin Eifler, Jón Otti Sigurðsson, Sabine A G Cuijpers, Ivo A Hendriks, Matty Verlaan-de Vries, Christian D Kelstrup, Chiara Francavilla, René H Medema, Jesper V Olsen,[...]. Mol Cell 2014
130
100

Chordoma: a systematic review of the epidemiology and clinical prognostic factors predicting progression-free and overall survival.
S H Bakker, W C H Jacobs, W Pondaag, H Gelderblom, R A Nout, P D S Dijkstra, W C Peul, C L A Vleggeert-Lankamp. Eur Spine J 2018
38
100

Allosteric Inhibition of Ubiquitin-like Modifications by a Class of Inhibitor of SUMO-Activating Enzyme.
Yi-Jia Li, Li Du, Jianghai Wang, Ramir Vega, Terry D Lee, Yunan Miao, Grace Aldana-Masangkay, Eric R Samuels, Baozong Li, S Xiaohu Ouyang,[...]. Cell Chem Biol 2019
25
100

Small ubiquitin-related modifier ligase activity of Mms21 is required for maintenance of chromosome integrity during the unperturbed mitotic cell division cycle in Saccharomyces cerevisiae.
Ragini Rai, Satya P M V Varma, Nikhil Shinde, Shilpa Ghosh, Srikala P Kumaran, Geena Skariah, Shikha Laloraya. J Biol Chem 2011
20
100

Sumoylation promotes optimal APC/C Activation and Timely Anaphase.
Christine C Lee, Bing Li, Hongtao Yu, Michael J Matunis. Elife 2018
21
100

MYC amplification and polysomy 8 in chondrosarcoma: array comparative genomic hybridization, fluorescent in situ hybridization, and association with outcome.
Carl Morrison, Michael Radmacher, Nehad Mohammed, David Suster, Herbert Auer, Susie Jones, Judy Riggenbach, Nicole Kelbick, Gary Bos, Joel Mayerson. J Clin Oncol 2005
44
100

Dedifferentiated chondrosarcoma: prognostic factors and outcome from a European group.
Robert J Grimer, Georg Gosheger, Antonie Taminiau, David Biau, Zdenek Matejovsky, Yehuda Kollender, Mikel San-Julian, Franco Gherlinzoni, Cristina Ferrari. Eur J Cancer 2007
121
100

Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome.
Twinkal C Pansuriya, Ronald van Eijk, Pio d'Adamo, Maayke A J H van Ruler, Marieke L Kuijjer, Jan Oosting, Anne-Marie Cleton-Jansen, Jolieke G van Oosterwijk, Sofie L J Verbeke, Daniëlle Meijer,[...]. Nat Genet 2011
298
100

Drug discovery: Controlling protein SUMOylation.
John S Schneekloth. Nat Chem Biol 2017
4
100

Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha.
Meelad M Dawlaty, Liviu Malureanu, Karthik B Jeganathan, Esther Kao, Claudio Sustmann, Samuel Tahk, Ke Shuai, Rudolf Grosschedl, Jan M van Deursen. Cell 2008
231
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.